Search publications, data, projects and authors
Étude des projections axonales sérotoninergiques dans un modèle murin de la maladie de Parkinson et des dyskinésies induites par la lévodopa





Objectives: The release of dopamine by serotonin (5-HT) afferent projections of the striatum is known to be a major pre-synaptic determinant of L-Dopa-induced dyskinesia, a debilitating side effect of the pharmacological treatment of the Parkinson’s disease. The fact that 5-HT axons are able to release dopamine in a nonphysiological manner following the administration of L-Dopa might lead to the expression of dyskinesias. Some striatal 5-HT axons are known to contain VGluT3 and we hypothesize that this vesicular glutamate transporter has a synergic effect on dopamine packaging into synaptic vesicles and its release. The main goal of this research project is to measure VGluT3 in 5-HT striatal afferent projections and to evaluate its role in the expression of dyskinesias. Methods: Eighteen C57Bl6 mice were divided in 3 experimental groups. Twelve mice received intracerebral injection of 6-hydroxydopamine (6-OHDA) in the medial forebrain bundle to lesion the striatal dopaminergic afferent projections. Systematic daily injections of L-Dopa (during 12 days) were administrated in 6 of these 6-OHDA-lesioned mice. The other 6 mice received injections of the vehicle only and served as controls. The abnormal involuntary movements (the equivalent of dyskinesias in primates) were scored using a well-known and widely used motor scale. Double immunofluorescence for the 5-HT membrane transporter (SERT) and VGluT3 was performed to evaluate the density of immunolabeled axon varicosities and assess statistical differences between the 3 experimental groups. Results: Among the 3 groups, only a small percentage of 5-HT axonal varicosities express VGluT3 and these doubly labeled varicosities often occur along the same axonal branch. There is no significant difference between the 3 experimental groups regarding the density of SERT or SERT/VGluT3 axon varicosities in the dorsal striatum. Conclusion: Our data indicate that the density of SERT or SERT/VGluT3 immunolabeled axon varicosities in the dorsal striatum is not correlated with the severity or the expression of abnormal involuntary movement following L-Dopa administration

Report a bug

Under construction

We're in Beta!

The GoTriple platform is still in Beta and we keep adding new features everyday. Check the project's website to see what's new and subscribe to our Mailing List.